None listed
Conditions
Interventions
Intervention1: guduchi Ghan Vati/Samshamani Vati: 1 gm per person/day, 500 mg two times (BID) for 30 days. Route would be oral
Control Intervention1: Hand sanitizer
Face Mask
Social Distancing: To be
Sponsors
Central Council for Research in Ayurvedic Sciences
Ministry of AYUSH
Eligibility
Inclusion criteria
Inclusion criteria: 1. Participants who are from a community where at least 1 confirmed case is already identified. 2. Participants who are ready to provide written/digital informed consent and who are willing to participate and follow the protocol requirements of the clinical study
Exclusion criteria
Exclusion criteria: • Known cases Covid-19. • Pregnant and Lactating females • Known cases of uncontrolled Diabetes and Hypertension • Participants having any medical or surgical condition that would require immediate medical or surgical intervention at the time of screening • Participants having immune compromised status like HIV, Hepatitis, Tuberculosis, Cancer etc. • Participants taking Steroid treatment and or any kind of immunosuppressive therapy • Participants participating in any other clinical study or having participated in any other study 1 month prior to screening in the present study. • Participants having a history of allergy to any medicine that is part of the Ayurvedic intervention. • Other conditions, which in the opinion of the investigators, makes the patient unsuitable for enrolment or could interfere with his participation in, and completion of the protocol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparative assessment of occurrence of COVID-19 infection in Clinically stable participants in community having at least 1 confirmed case already identified with control arm of Standard Prophylactic CareTimepoint: 0, two weeks, 4 weeks, 6 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparative assessment of severity of COVID-19 infection in participants taking Guduchi Ghan Vati/ Sudarshan Ghan Vati and the control arm in following situations: 1. Assessment of participants not requiring hospitalization 2. Severity of symptoms of hospitalized patients in wards 3. Patients requiring ICU admission / Ventilator support 4. Global assessment of overall change as per the investigator (Efficacy assessment) Timepoint: Total 45 days (0, 2, 4, 6 weeks) | — |
Countries
India
Contacts
Public ContactVipin Sharma
CCRAS
Outcome results
None listed